Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000935836-25-000732·IN8BIO, INC.
Schedule 13G ownership disclosure
IN8bio, Inc.
Common Stock · CUSIP: 45674E208
Event date: 2025-12-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Stonepine Capital Management, LLC
Shares: 1,007,990.00 · Class: 9.9%
- Stonepine Capital, L.P.
Shares: 1,007,990.00 · Class: 9.9%
- Stonepine GP, LLC
Shares: 1,007,990.00 · Class: 9.9%
- Jon M. Plexico
Shares: 1,007,990.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-25-000732
- Form type
- SCHEDULE 13G
- Filer
- IN8BIO, INC.
- CIK
- CIK 1740279
- Filed
- Dec 22, 2025
- Reporting period
- Dec 19, 2025
- Description
- Schedule 13G beneficial ownership